Christophe Weber (Miho Takahashi/The Yomiuri Shimbun via AP Images)
Takeda abandons one of its top experimental drugs following a slap down at the FDA
Takeda has abandoned one of the drugs that had once sat at the top of its list of first- or best-in-class drug hopefuls.
Just weeks …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
